Welcome to LookChem.com Sign In|Join Free
  • or
1-Piperazinecarboxylic acid, 4-(2,2,2-trifluoroethyl)-, phenylmethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

629625-96-3

Post Buying Request

629625-96-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

629625-96-3 Usage

Molecular class

Piperazine compounds

Common use

Intermediate in the synthesis of various pharmaceuticals and agrochemicals

Potential applications

Medicinal chemistry and drug discovery

Use as a building block

Production of various organic compounds

Safety

Handle with care and follow appropriate safety protocols in a laboratory setting.

Check Digit Verification of cas no

The CAS Registry Mumber 629625-96-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,9,6,2 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 629625-96:
(8*6)+(7*2)+(6*9)+(5*6)+(4*2)+(3*5)+(2*9)+(1*6)=193
193 % 10 = 3
So 629625-96-3 is a valid CAS Registry Number.

629625-96-3Relevant academic research and scientific papers

An Improved Stereocontrolled Access Route to Piperidine or Azepane β-Amino Esters and Azabicyclic β- and γ-Lactams; Synthesis of Novel Functionalized Azaheterocyles

Ouchakour, Lamiaa,Nonn, Melinda,Remete, Attila M.,Kiss, Loránd

, p. 3874 - 3885 (2021/06/16)

An improved, efficient synthesis of some functionalized saturated azaheterocycles has been accomplished by controlled functionalization of various readily available cyclic compounds containing ring C=C bond. The stereocontrolled synthetic concept was based on the oxidative ring cleavage of various unsaturated scaffolds across ozonolysis followed by ring closing with double reductive amination with primary alkylamines or fluorinated alkylamines. The protocol provided versatile azaheterocyclic derivatives with a piperidine or azepane framework.

NOVEL PHYSIOLGICALLY ACTIVE SUBSTANCES

-

Page/Page column 135-136, (2008/06/13)

The present invention relates to a compound represented by the formula (I): (wherein, R3, R6, R7 and R21 are the same as or different from one another and each represents a hydroxyl group etc.), a pharmacologically acceptable salt thereof or a hydrate of them. The compound (I) of the present invention suppresses angiogenesis, in particular, suppresses VEGF production in a hypoxic condition and is useful as a therapeutic agent for treating solid cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 629625-96-3